C4 Therapeutics Inc (CCCC) — Financial Flexibility Index
C4 Therapeutics Inc (CCCC) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-29.88 Million (operating CF $-29.94 Million minus capex $64.00K) represents 0% of total liabilities ($94.61 Million). Check CCCC capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
C4 Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for C4 Therapeutics Inc across 8 annual periods. See C4 Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for C4 Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for C4 Therapeutics Inc. For the full company profile including market capitalisation, see market value of C4 Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-98.09 Million | $-98.69 Million | $102.49 Million | ▼ -96.8% |
| 2024 | -0.49x | $-64.98 Million | $-65.16 Million | $133.62 Million | ▲ +39.7% |
| 2023 | -0.81x | $-105.13 Million | $-106.84 Million | $130.34 Million | ▼ -13.7% |
| 2022 | -0.71x | $-100.44 Million | $-105.94 Million | $141.61 Million | ▲ +3.0% |
| 2021 | -0.73x | $-85.69 Million | $-86.97 Million | $117.16 Million | ▼ -31.1% |
| 2020 | -0.56x | $-66.60 Million | $-67.25 Million | $119.35 Million | ▼ -325.5% |
| 2019 | 0.25x | $56.96 Million | $55.61 Million | $230.22 Million | ▲ +491.7% |
| 2018 | -0.06x | $-14.29 Million | $-16.98 Million | $226.24 Million | — |